Follow The Filings

INBX Inhibrx Biosciences

Inhibrx Biosciences earnings company data as of 4:47 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -2.34 —
Rev — — —

Insider trades

Open-market buys and sales by INBX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INBX insider trades
  • $6.3M bought by 3 insiders
  • $279K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Mark Lappe CEO
    Buy
    $849K 10,040 shares at $84.56 +6.3% to stake
    Traded Oct 14 Filed Oct 14
    ↗
  2. Mark Lappe CEO
    Buy
    $999K 10,000 shares at $99.88 +1.4% to stake
    Traded Sep 25–28 Filed Sep 28
    ↗
  3. Jon Faiz Kayyem Director
    Buy
    $500K 5,000 shares at $100.00 +1.2% to stake
    Traded Sep 23 Filed Sep 23
    ↗
  4. Jon Faiz Kayyem Director
    Buy
    $500K 5,000 shares at $100.00 +1.2% to stake
    Traded Sep 16 Filed Sep 17
    ↗
  5. Kimberly Manhard Director
    Sale
    $164K 1,500 shares at $109.03 17% of stake
    Traded Sep 11–15 Filed Sep 15
    ↗
  6. Kimberly Manhard Director
    Sale
    $115K 1,000 shares at $115.47 10% of stake
    Traded Sep 8–9 Filed Sep 10
    ↗
  7. Jon Faiz Kayyem Director
    Buy
    $568K 5,000 shares at $113.52 +1.2% to stake
    Traded Sep 8 Filed Sep 8
    ↗
  8. Mark Lappe CEO
    Buy
    $2.6M 25,000 shares at $105.82 +3.5% to stake
    Traded Sep 8 Filed Sep 8
    ↗
  9. Douglas Forsyth Director
    Buy
    $287K 2,500 shares at $114.65 +1.1% to stake
    Traded Sep 8 Filed Sep 8
    ↗
  10. Viking Global Investors LP 10% owner, +7 joint filers
    Sale
    $11.3M 350,000 shares at $32.25 77% of stake
    Traded Oct 7, 2025 Filed Oct 9, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.03,3.02,7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.